Skip to content

A Comparison of Tissue Adhesive Material and Suture as Wound-closure Techniques Following Carpal Tunnel Decompression

A Comparison of Tissue Adhesive Material and Suture as Wound-closure Techniques

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05747989
Enrollment
98
Registered
2023-02-28
Start date
2022-06-01
Completion date
2023-08-01
Last updated
2023-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome

Brief summary

Participants will be randomly assigned to suture-based wound closure (n=50) or tissue adhesive-based wound closure (n=50) with two-component skin adhesive Glubran Tiss 2®. The outcomes will be assessed during the follow-up period at intervals of 2, 6, and 12 weeks postoperatively. A scar assessment will be using the POSAS (Patient and Observer Scar Assessment Scale) and cosmetic VAS (Visual Analog Scale). The VNRS (Verbal Number Rating Scale) will used to assess pain.

Interventions

PROCEDUREtwo-component skin adhesive, Glubran Tiss 2

After subcutaneous stitches a two-component skin adhesive, Glubran Tiss 2®, will be applied. G Each subject will receive 0.35 mL of Glubran Tiss® in the open wound, and before bandaging, subjects rested for 20 minutes for a polymerization process.

PROCEDUREskin is stitched with transcutaneous nylon sutures

The skin is stitched with transcutaneous nylon sutures (polypropylene-polyethylene monofilament, non-absorbable surgical suture) 4-0

Sponsors

University of Split, School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 99 Years
Healthy volunteers
No

Inclusion criteria

(all of the above) * age \>18 years * carpal tunnel syndrome * weakness of thumb abduction * with atrophy of the thenar * median nerve conduction impairment estimated by electromyography

Exclusion criteria

(one or more) * threatening haemorrhagic complications (patients with peroral anticoagulation and/or antithrombotic therapy) * previous wrist trauma or surgery on the wrist region * another aetiology of neuropathy * previous allergic reactions (with lidocaine, cyanoacrylate, formaldehyde, tapes, or adhesives) * personal or family history of keloids or hypertrophic scars * severe general illness with cachexia

Design outcomes

Primary

MeasureTime frameDescription
scar assessment - using the Patient and Observer Scar Assessment Scale (POSAS)12 weeksscar assessment The POSAS is made up of two scales: the patient scale and the observer scale; each of the six components is scored numerically on a scale of 1 to 10. The component scores are then added together; the worst scar would receive a score of 60, while the best scar would receive a score of 6

Secondary

MeasureTime frameDescription
Verbal Number Rating Scale (VNRS) - to assess the degree of pain12 weeksdegree of pain A Verbal Number Rating Scale (VNRS) was used to assess the degree of pain in the hand before and the day after surgery, as well as at 2, 6, and 12-week intervals during the follow-up period. The VNRS is a verbal self-report instrument with a 0 - 10 numeric rating scale, where 0 represents no pain and 10 represents the most severe pain possible
VAS - Visual Analog Scale12 weeksscar assessment VAS (Visual Analog Scale) assessment form was filled out by the patient at the 2, 6, and 12-week intervals. The cosmetic-VAS is a 0-100 scale with worst scar written at the left end (0) and best scar written at the right end (100)

Countries

Croatia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026